Certified Final Exam for LCAS Verified Questions and Answers

Certified Final Exam for LCAS Verified Questions and Answers Medication Assisted Treatment (MAT) - CORRECT ANSWER-any treatment for for a SUD that includes a pharmacologic intervention as part of a comprehensive substance abuse treatment plan with ultimate goal of patient recovery with full social function alcohol dependence - CORRECT ANSWER-FDA approved disulfiram, naltrexone, and acamprosate for treatment of ____________ opioid dependence - CORRECT ANSWER-FDA approved methadone, naltrexone, and buprenorphine for treatment of _____________ alcohol, nicotine and opioid - CORRECT ANSWER-currently, FDA has approved medications effective for MAT in three types of SUD: _____________, _____________ and __________ dependence acamprosate, disulfiram, naltrexone - CORRECT ANSWER-three drugs approved for alcohol dependence Acamprosate (Campral) - CORRECT ANSWER-used to treat alcohol dependence; reduces symptoms of protracted withdrawal (i.e. insomnia, anxiety, restlessness, and dysphoria) by normalizing brain systems disrupted by chronic alcohol consumption; more effective in pts with severe alcohol use disorders Disulfiram (Antabuse) - CORRECT ANSWER-used to treat alcohol dependence; inhibits an enzyme involved in the metabolism in alcohol, causing unpleasant reaction (i.e. flushing, nausea, and heart palpitations) if alcohol is consumed after taking the medication; compliance can be a problem but is very effective with motivated pts. Naltrexone (Vivitrol or Revia) - CORRECT ANSWER-used to treat alcohol dependence; blocks receptors involved in rewarding effects of drinking and in cravings for alcohol. Reduces relapse of heavy drinking behavior and is highly effective in some but not all pts., where varied outcomes could be due to genetic factors. Available in both oral tablet and long-acting injectable form Methadone, Buprenorphine, Naltrexone - CORRECT ANSWER-three FDA approved drugs used in MAT for opioid use disorders Methadone - CORRECT ANSWER-prevents opioid withdrawal and craving symptoms by activating opiate receptors in the brain. Long history of use in treatment of opioid dependence. Buprenorphine - CORREC